 Osmolality
 Acid –base & electrolyte balance
 Toxin removal
 Hormones (renin , prostaglandins , kinins)
 Vitamin D metabolism
 Erythropoietin
 Outer granular layer of the kidney that contains most of
the nephrons
 Highly vascular (85% -90% of RBF)
 Contains bowmans capsule and convoluted tubules
 Less vascular
 contains renal pyramids, renal papillae, renal calyces
(minor/major),renal pelvis
 part of nephron, not located in the cortex
 Site for salt, water and urea absorption
 Functional unit of kidney
 1 million functional unit in each kidney
Renal corpuscle Renal tubule
glomerulus Proximal convoluted tubules
Glomerular capsule Loop of henle
Distal convoluted tubule
Collecting duct
Juxtaglomerular apparatus
Cortical nephron juxtamedullary nephron
Short loop of henle Long loop of henle
Occupy renal cortex Deep into the renal medulla
Do not contain vasa recta Long loop of henle are accompanied
by the vasa recta
85% of nephrons are cortical nephrons Responsible for corticopapillary
osmotic gradient
15%of nephrons are juxta medullary
nephrons
 Glomerulus surrounded by a glomerular capsule
 Present with in the renal cortex
 Endothelial cells in glomeruli
 Epithelial cells of bowman's capsule
 Mesangial cells
 Ultrafiltration of blood
Filtation membrane therefore prevent the passage of :
 Blood cells
 Large proteins
 Most negatively charged molecule more than 8nm
 The PCT is responsible for the majority of the
reabsorption.
 Reabsorption : Na+ ,Cl-, water ,bicarbonate , glucose ,
protein ,amino acids , k+ , Mg2+ , Ca2+ , phosphate , uric
acid , urea
 Secretion: Organic anions and cations
 There are 3 sections to the loop of Henle:
 1. Thin descending limb
 2. Thin ascending limb
 3. Thick ascending limb
 Reabsortion : Na+, Cl+, water , k+ , Ca2+ ,Mg2+
,establishes concentration gradient within medulla
 countercurrent multiplier (the loop of Henle)
 countercurrent exchange (the vasa recta)
 Highly vascular
 20%to 25% of Cardiac output
Afferent Arteriole
 Transport arterial blood to glomerulus for filtration
 High –pressure capillary bed
Efferent Arteriole
 the blood that is not filtered begins its passage to the
venous system
 It offers resistance to blood flow
 transport reabsorbed materials from the PCT and DCT
into kidney veins
 Low –pressure bed formed by efferent vessel
Vasa recta :
 Hairpin loops
 Dip down among the loop of henle.
 Vasoconstriction of renal arterioles, which leads to a
decrease in RBF, is produced by activation of the
sympathetic nervous system and angiotensin II.
 At low concentrations, angiotensin II preferentially
constricts efferent arterioles, thereby “protecting”
(increasing) the GFR.
 20% of cardiac output goes to kidney
 Clearance: volume of blood that is completely cleared of
a substance per unit of time
 RPF most commonly measured by PAH clearance
• Kidney can maintain a nearly constant GFR despite
fluctuations in in systemic arterial BP
 Autoregulated between MAP of 50 and 150 mmhg
Mechanism :
a)Myogenic mechanism
b) Tubuloglomerular feedback
 RBF= RPF/(1- Hematocrit)
 Severity of renal impairment
 Cause of renal impairment
 Progression of renal disease
Urine output :
 simple method to evaluation of intaoperative
&postoperative renal function
 Oliguria – urine flow less then 0.5ml/kg/h
 It correlates with AKI .
 And fluid administration .
 Transient oliguria is almost invetable
 Due to : hypotension ( hypovolemia or surgical stress)
 Anuria suggests post renal obstruction
 Best measure of renal function
 Calculated from timed urine volume +urinary and
plasma creatine concentration
 Or from direct measurement of the clearance of either
endogenous or exogenous substance
 GFR: 125Ml /min -140 ml /min
 Decreases 1% per year after age of 20
 Clinical manifestation of urenia appear when GFR falls
below 15ml/min/1.73m3
 Factors governing filtration rate at capillary beds
1. Total surface area available for filtration
2. Filtration membrane permeability
3. Net filtration pressure
 Ratio GFR to RPF called filtration fraction (FF);
normally 20%
 The driving force for glomerular filtration is the net
ultrafiltration pressure across the glomerular
capillaries.
 GFR can be expressed by the Starling equation:
 GFR=Kf [(PGC −PBS )−(πGC −πBS )]
 Kf is the filtration coefficient
 Creatinine is endogenous marker of renal filtration
 results from the metabolism of creatine in the liver
 It is freely filtered and not reabsorbed
 Most reliable measure of GFR
 0.6 to 1.0 mg /dl in women
 0.8 to 1.3 mg/dl in male
 Varies with muscle mass, rate of catabolism
 Protein intake and physical activity
 low GFR overestimate renal function as little creatinine
is secreted
 Urea is formed in liver by deamination of amino acids
and conversion to ammonia by arginine cycle
 Not an indicator of GFR
 Rapidly reabsorbed by the tubules
 Absorption of blood from G.I tract ,steroids and sepsis
BUN
 Malnutrition or liver disease BUN
 Ratio of BUN to serum creatinine ratio
10 and 15 to 1
 useful in diagnosis of renal failure from prerenal causes
vs acute tubular necrosis
 It is assessed by measuring the urine concentrating
ability
 Protein urea reflect renal tubular damage
 Urinary specific gravity is an index of renal tubular
function
 Specific gravity higher than 1.018 suggests that the
ability of renal tubules to concentrate is adeqate
 Transient proteinuria is associated with fever ,CHF
seizure activity ,pancreatitis and exercise
 Microalbuminuria is the earliest sign of diabetic
nephropathy
 Severe proteinuria may result in hypoalbuminemia
 Associated in plasma oncotic pressure and in
unbound drug concentration
 Measure of the % of filtered sodium that is excreted in
the urine
 Useful in differentiating pre-renal and renal cause of
azotemia
 FeNa higher than 2% suggestive of acute tubular
necrosis
 FeNa of less then 1% suggestive of prerenal azotemia
 Urinalysis :
a. Gross appearance
b. Microscopic
 Serum and urine electrolytes
 Dipsticks
 Imaging studies
a. CT scan
b. MRI
 Markers for GFR :
a. Cystatin C
b. Beta -2 microglobulin
 Biomarkers for tubular function:
a. Albumin
b. Transferrin
c. Lambda and kappa light chain
d. Immunoglobulin C
 Biomarkers reflecting tubular cell response to
stress :
a. Neutrophil gelatinase associated lipocalin
b. Urinary interleukin 18
c. Kidney injury molecule1
 Decrease GFR and intraoperative urine flow due to
decreased cardiac output and arterial blood pressure .
 Renal injury occurs unless there is preexisting renal
disease , nephrotoxic drug ,hypovolemia or
combination.
 Volatile anesthetics induce mild to moderate reduction
in RBF and GFR mainly due myocardial depression and
vasodilatory effects
 Can be attenuated by prior intravenous hydration
 Decrease in GFR by decreasing renal perfusion
pressure either by decreasing systemic vascular
resistance (isoflurane or sevoflurane) or cardiac output
(halothane).
 This decrease in GFR is exacerbated by hypovolemia
and the release of catecholamines and antidiuretic
hormone as a response to painful stimulation during
surgery.
KDIGO defines AKI as any of the following:
 Increase in serum creatinine by 0.3mg/dL or more
within 48 hours or
 Increase in serum creatinine to 1.5 times baseline or
more within the last 7 days or
 Urine output less than 0.5 mL/kg/h for 6 hours
 Chronic Kidney Disease (CKD) refers to an irreversible
and progressive deterioration in renal function which
develops over months to years.
 It causes a multi-systemic dysfunction which can be
caused by the primary disease process, effects of
uremia or both
 Stage 1: Kidney damage with normal or ↑ GFR (≥90
ml/min)
 Stage 2: Kidney damage with mild ↓ GFR (60–89
ml/min)
 Stage 3; Moderate ↓ GFR (30–59 ml/min)
 Stage 4: Severe ↓ GFR (15–29 ml/min)
 Stage 5: Kidney failure with GFR<15 or need to dialysis
 Hypertension
 Diabetes Mellitus
 Glomerulonephritis
 SLE
 HIV
 Sickle Cell Disease
 Metabolic acidosis
 Altered haemostasis
a. platelet dysfunction
b. prothrombotic tendency and reduced fibrinolysis
 Autonomic neuropathy
 delayed gastric emptying
 parasympathetic dysfunction
 Uremia
 Hypertension
 Fluid and electrolytes abnormalities
a. volume overload
b. hyperkalaemia
c. Hypocalcaemia
d. Hyponatraemia
 Hypoalbuminaemia
 Increased Cardiovascular mortality
 Increased risk for infections
 Bone disease
 The symptomatic and supportive treatment of
hypotension and hypovolemia.
 Diuretics for volume overload
 Correction electrolyte derangements (hyperkalemia,
acidosis, etc)
 Treatment of sepsis
 Removal of nephrotoxic agents
 These patients should be optimized using a
multidisciplinary approach as CKD affects all organ
systems.
 CKD is strongly associated with an accelerated form of
ischaemic heart disease and as such, all patients
should have a baseline ECG.
 Vascular access should be chosen carefully; current
and potential fistula sites should be avoided.
 Patients with chronic renal failure should receive
dialysis treatment 12-24hrs before planned surgery to
optimize their electrolyte, metabolic and volume status.
 Opioid- based anesthetics are considerably more
effective than volatile anesthetics in suppressing the
release of catecholamine's, angiotensin ll, aldosterone
 ketamine RBF but urine flow rate
(sympathetic activation)
Preserve RBF during hemorrhagic hypovolemia .
 Degraded in basic carbon dioxide absorbents (Barium
Hydroxide and Soda lime) into a vinyl ether called
compound A.
 Compound A has been implicated to cause renal injury
through fluoride toxicity (animal studies).
 High intra-renal fluoride concentrations impair the
concentrating ability of the kidney and may theoretically
lead to non-oliguric renal failure.
 It is considered safe even in patients with renal
impairment as long as prolonged low-flow anesthesia is
avoided. (Minimum flow ≥ 2 L/min)
 Caused dose-dependent abnormalities post-surgery.
 It causes vasopressin-resistant polyuria, serum
hyperosmolality, hypernatremia, increased
concentrations of serum urea nitrogen and inorganic
fluoride, and decreased urinary potassium, sodium,
osmolality, and urea nitrogen concentrations.
 Therefore, clinically it is no longer used
 Positive-pressure ventilation used during general
anesthesia can decrease venous return, cardiac output,
renal blood flow, and GFR.
 Decreased cardiac output leads to release of
catecholamine's, ADH, rennin, and angiotensin II with
the activation of the sympathoadrenal system and
resultant decrease in renal blood flow.
 Spinal and epidural anaesthesia only slightly decrease
GFR and RBF in proportion to the decrease in mean
arterial pressure.
 The preexisting intravascular volume and the quantity
of intravenous fluids given strongly influence the renal
response to spinal and epidural anaesthesia.
 There is also decreased diuresis and a marked fall in
sodium excretion.
 These trends are gradually reversed during recovery.
 Inhalational anaesthetics generally reduce GFR and
urine output, mainly by extra-renal effects that are
attenuated by pre- operative hydration.
 Opioids, barbiturates and benzodiazepines also reduce
GFR and urine output.
 The effects of regional anesthesia seem to be less than
those of general anesthesia and are related to changes
in systemic hemodynamic.
 Mechanical ventilation decreases urine volume and
sodium excretion to an extent that depends on the
increase in intrathoracic pressure.
 Miller anesthesia
 Stoelting’s anesthesia & co-exiting Diesease
 Pharmacology and physiology for anesthesia

RENAL FUNCTION TEST.pptx

  • 2.
     Osmolality  Acid–base & electrolyte balance  Toxin removal  Hormones (renin , prostaglandins , kinins)  Vitamin D metabolism  Erythropoietin
  • 5.
     Outer granularlayer of the kidney that contains most of the nephrons  Highly vascular (85% -90% of RBF)  Contains bowmans capsule and convoluted tubules
  • 6.
     Less vascular contains renal pyramids, renal papillae, renal calyces (minor/major),renal pelvis  part of nephron, not located in the cortex  Site for salt, water and urea absorption
  • 7.
     Functional unitof kidney  1 million functional unit in each kidney
  • 8.
    Renal corpuscle Renaltubule glomerulus Proximal convoluted tubules Glomerular capsule Loop of henle Distal convoluted tubule Collecting duct Juxtaglomerular apparatus
  • 9.
    Cortical nephron juxtamedullarynephron Short loop of henle Long loop of henle Occupy renal cortex Deep into the renal medulla Do not contain vasa recta Long loop of henle are accompanied by the vasa recta 85% of nephrons are cortical nephrons Responsible for corticopapillary osmotic gradient 15%of nephrons are juxta medullary nephrons
  • 11.
     Glomerulus surroundedby a glomerular capsule  Present with in the renal cortex
  • 12.
     Endothelial cellsin glomeruli  Epithelial cells of bowman's capsule  Mesangial cells
  • 13.
     Ultrafiltration ofblood Filtation membrane therefore prevent the passage of :  Blood cells  Large proteins  Most negatively charged molecule more than 8nm
  • 14.
     The PCTis responsible for the majority of the reabsorption.  Reabsorption : Na+ ,Cl-, water ,bicarbonate , glucose , protein ,amino acids , k+ , Mg2+ , Ca2+ , phosphate , uric acid , urea  Secretion: Organic anions and cations
  • 15.
     There are3 sections to the loop of Henle:  1. Thin descending limb  2. Thin ascending limb  3. Thick ascending limb  Reabsortion : Na+, Cl+, water , k+ , Ca2+ ,Mg2+ ,establishes concentration gradient within medulla
  • 16.
     countercurrent multiplier(the loop of Henle)  countercurrent exchange (the vasa recta)
  • 18.
     Highly vascular 20%to 25% of Cardiac output
  • 20.
    Afferent Arteriole  Transportarterial blood to glomerulus for filtration  High –pressure capillary bed Efferent Arteriole  the blood that is not filtered begins its passage to the venous system  It offers resistance to blood flow
  • 21.
     transport reabsorbedmaterials from the PCT and DCT into kidney veins  Low –pressure bed formed by efferent vessel Vasa recta :  Hairpin loops  Dip down among the loop of henle.
  • 22.
     Vasoconstriction ofrenal arterioles, which leads to a decrease in RBF, is produced by activation of the sympathetic nervous system and angiotensin II.  At low concentrations, angiotensin II preferentially constricts efferent arterioles, thereby “protecting” (increasing) the GFR.
  • 23.
     20% ofcardiac output goes to kidney  Clearance: volume of blood that is completely cleared of a substance per unit of time  RPF most commonly measured by PAH clearance
  • 24.
    • Kidney canmaintain a nearly constant GFR despite fluctuations in in systemic arterial BP  Autoregulated between MAP of 50 and 150 mmhg Mechanism : a)Myogenic mechanism b) Tubuloglomerular feedback  RBF= RPF/(1- Hematocrit)
  • 25.
     Severity ofrenal impairment  Cause of renal impairment  Progression of renal disease
  • 27.
    Urine output : simple method to evaluation of intaoperative &postoperative renal function  Oliguria – urine flow less then 0.5ml/kg/h  It correlates with AKI .  And fluid administration .
  • 28.
     Transient oliguriais almost invetable  Due to : hypotension ( hypovolemia or surgical stress)  Anuria suggests post renal obstruction
  • 29.
     Best measureof renal function  Calculated from timed urine volume +urinary and plasma creatine concentration  Or from direct measurement of the clearance of either endogenous or exogenous substance
  • 30.
     GFR: 125Ml/min -140 ml /min  Decreases 1% per year after age of 20  Clinical manifestation of urenia appear when GFR falls below 15ml/min/1.73m3
  • 31.
     Factors governingfiltration rate at capillary beds 1. Total surface area available for filtration 2. Filtration membrane permeability 3. Net filtration pressure  Ratio GFR to RPF called filtration fraction (FF); normally 20%
  • 32.
     The drivingforce for glomerular filtration is the net ultrafiltration pressure across the glomerular capillaries.  GFR can be expressed by the Starling equation:  GFR=Kf [(PGC −PBS )−(πGC −πBS )]  Kf is the filtration coefficient
  • 34.
     Creatinine isendogenous marker of renal filtration  results from the metabolism of creatine in the liver  It is freely filtered and not reabsorbed  Most reliable measure of GFR
  • 35.
     0.6 to1.0 mg /dl in women  0.8 to 1.3 mg/dl in male  Varies with muscle mass, rate of catabolism  Protein intake and physical activity  low GFR overestimate renal function as little creatinine is secreted
  • 36.
     Urea isformed in liver by deamination of amino acids and conversion to ammonia by arginine cycle  Not an indicator of GFR  Rapidly reabsorbed by the tubules
  • 37.
     Absorption ofblood from G.I tract ,steroids and sepsis BUN  Malnutrition or liver disease BUN  Ratio of BUN to serum creatinine ratio 10 and 15 to 1  useful in diagnosis of renal failure from prerenal causes vs acute tubular necrosis
  • 38.
     It isassessed by measuring the urine concentrating ability  Protein urea reflect renal tubular damage
  • 39.
     Urinary specificgravity is an index of renal tubular function  Specific gravity higher than 1.018 suggests that the ability of renal tubules to concentrate is adeqate
  • 40.
     Transient proteinuriais associated with fever ,CHF seizure activity ,pancreatitis and exercise  Microalbuminuria is the earliest sign of diabetic nephropathy  Severe proteinuria may result in hypoalbuminemia  Associated in plasma oncotic pressure and in unbound drug concentration
  • 41.
     Measure ofthe % of filtered sodium that is excreted in the urine
  • 42.
     Useful indifferentiating pre-renal and renal cause of azotemia  FeNa higher than 2% suggestive of acute tubular necrosis  FeNa of less then 1% suggestive of prerenal azotemia
  • 43.
     Urinalysis : a.Gross appearance b. Microscopic  Serum and urine electrolytes  Dipsticks  Imaging studies a. CT scan b. MRI
  • 44.
     Markers forGFR : a. Cystatin C b. Beta -2 microglobulin  Biomarkers for tubular function: a. Albumin b. Transferrin c. Lambda and kappa light chain d. Immunoglobulin C
  • 45.
     Biomarkers reflectingtubular cell response to stress : a. Neutrophil gelatinase associated lipocalin b. Urinary interleukin 18 c. Kidney injury molecule1
  • 46.
     Decrease GFRand intraoperative urine flow due to decreased cardiac output and arterial blood pressure .  Renal injury occurs unless there is preexisting renal disease , nephrotoxic drug ,hypovolemia or combination.
  • 47.
     Volatile anestheticsinduce mild to moderate reduction in RBF and GFR mainly due myocardial depression and vasodilatory effects  Can be attenuated by prior intravenous hydration
  • 48.
     Decrease inGFR by decreasing renal perfusion pressure either by decreasing systemic vascular resistance (isoflurane or sevoflurane) or cardiac output (halothane).  This decrease in GFR is exacerbated by hypovolemia and the release of catecholamines and antidiuretic hormone as a response to painful stimulation during surgery.
  • 49.
    KDIGO defines AKIas any of the following:  Increase in serum creatinine by 0.3mg/dL or more within 48 hours or  Increase in serum creatinine to 1.5 times baseline or more within the last 7 days or  Urine output less than 0.5 mL/kg/h for 6 hours
  • 51.
     Chronic KidneyDisease (CKD) refers to an irreversible and progressive deterioration in renal function which develops over months to years.  It causes a multi-systemic dysfunction which can be caused by the primary disease process, effects of uremia or both
  • 52.
     Stage 1:Kidney damage with normal or ↑ GFR (≥90 ml/min)  Stage 2: Kidney damage with mild ↓ GFR (60–89 ml/min)  Stage 3; Moderate ↓ GFR (30–59 ml/min)  Stage 4: Severe ↓ GFR (15–29 ml/min)  Stage 5: Kidney failure with GFR<15 or need to dialysis
  • 53.
     Hypertension  DiabetesMellitus  Glomerulonephritis  SLE  HIV  Sickle Cell Disease
  • 54.
     Metabolic acidosis Altered haemostasis a. platelet dysfunction b. prothrombotic tendency and reduced fibrinolysis  Autonomic neuropathy  delayed gastric emptying  parasympathetic dysfunction
  • 55.
     Uremia  Hypertension Fluid and electrolytes abnormalities a. volume overload b. hyperkalaemia c. Hypocalcaemia d. Hyponatraemia  Hypoalbuminaemia  Increased Cardiovascular mortality  Increased risk for infections  Bone disease
  • 56.
     The symptomaticand supportive treatment of hypotension and hypovolemia.  Diuretics for volume overload  Correction electrolyte derangements (hyperkalemia, acidosis, etc)  Treatment of sepsis  Removal of nephrotoxic agents
  • 57.
     These patientsshould be optimized using a multidisciplinary approach as CKD affects all organ systems.  CKD is strongly associated with an accelerated form of ischaemic heart disease and as such, all patients should have a baseline ECG.
  • 58.
     Vascular accessshould be chosen carefully; current and potential fistula sites should be avoided.  Patients with chronic renal failure should receive dialysis treatment 12-24hrs before planned surgery to optimize their electrolyte, metabolic and volume status.
  • 59.
     Opioid- basedanesthetics are considerably more effective than volatile anesthetics in suppressing the release of catecholamine's, angiotensin ll, aldosterone  ketamine RBF but urine flow rate (sympathetic activation) Preserve RBF during hemorrhagic hypovolemia .
  • 60.
     Degraded inbasic carbon dioxide absorbents (Barium Hydroxide and Soda lime) into a vinyl ether called compound A.  Compound A has been implicated to cause renal injury through fluoride toxicity (animal studies).
  • 61.
     High intra-renalfluoride concentrations impair the concentrating ability of the kidney and may theoretically lead to non-oliguric renal failure.  It is considered safe even in patients with renal impairment as long as prolonged low-flow anesthesia is avoided. (Minimum flow ≥ 2 L/min)
  • 62.
     Caused dose-dependentabnormalities post-surgery.  It causes vasopressin-resistant polyuria, serum hyperosmolality, hypernatremia, increased concentrations of serum urea nitrogen and inorganic fluoride, and decreased urinary potassium, sodium, osmolality, and urea nitrogen concentrations.  Therefore, clinically it is no longer used
  • 67.
     Positive-pressure ventilationused during general anesthesia can decrease venous return, cardiac output, renal blood flow, and GFR.  Decreased cardiac output leads to release of catecholamine's, ADH, rennin, and angiotensin II with the activation of the sympathoadrenal system and resultant decrease in renal blood flow.
  • 68.
     Spinal andepidural anaesthesia only slightly decrease GFR and RBF in proportion to the decrease in mean arterial pressure.  The preexisting intravascular volume and the quantity of intravenous fluids given strongly influence the renal response to spinal and epidural anaesthesia.  There is also decreased diuresis and a marked fall in sodium excretion.  These trends are gradually reversed during recovery.
  • 69.
     Inhalational anaestheticsgenerally reduce GFR and urine output, mainly by extra-renal effects that are attenuated by pre- operative hydration.  Opioids, barbiturates and benzodiazepines also reduce GFR and urine output.
  • 70.
     The effectsof regional anesthesia seem to be less than those of general anesthesia and are related to changes in systemic hemodynamic.  Mechanical ventilation decreases urine volume and sodium excretion to an extent that depends on the increase in intrathoracic pressure.
  • 71.
     Miller anesthesia Stoelting’s anesthesia & co-exiting Diesease  Pharmacology and physiology for anesthesia